Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

1.1K
Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
1.1K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Resource impact of bronchiectasis and associated exacerbations: based on a 5-year prospective observational cohort study (BronchUK).

BMJ open respiratory research·2026
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

The Lancet. Respiratory medicine·2026

Related Experiment Video

Updated: May 4, 2026

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

75.1K

The bronchiectasis severity index. An international derivation and validation study.

James D Chalmers1, Pieter Goeminne, Stefano Aliberti

  • 11 Tayside Respiratory Research Group, University of Dundee, Dundee, United Kingdom.

American Journal of Respiratory and Critical Care Medicine
|December 17, 2013
PubMed
Summary

The Bronchiectasis Severity Index (BSI) helps identify patients at high risk for mortality, hospitalizations, and exacerbations. This validated tool aids in clinical decision-making for bronchiectasis management.

More Related Videos

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

13.5K

Related Experiment Videos

Last Updated: May 4, 2026

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

75.1K
An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

13.5K

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Clinical Epidemiology
  • Medical Informatics

Background:

  • Bronchiectasis lacks validated risk stratification tools for morbidity and mortality.
  • Identifying high-risk patients is crucial for targeted research and interventions.
  • Current management strategies require better tools to predict adverse outcomes.

Purpose of the Study:

  • To derive and validate the Bronchiectasis Severity Index (BSI).
  • To establish a reliable tool for predicting mortality, hospitalization, and exacerbations in bronchiectasis patients.
  • To improve risk stratification in clinical practice.

Main Methods:

  • Prospective cohort derivation (n=608) in Edinburgh, UK (2008-2012).
  • Cox proportional hazard regression identified predictors of mortality and hospitalization over 4 years.
  • Validation in four independent international cohorts (total n=702).

Main Results:

  • Key predictors for hospitalization: prior admissions, dyspnea, low FEV1, Pseudomonas aeruginosa, and extent of lung involvement.
  • Key predictors for mortality: age, low FEV1, low BMI, prior hospitalization, and exacerbation frequency.
  • The BSI demonstrated strong predictive accuracy (AUC for mortality: 0.80; hospitalization: 0.88) and differentiated risk groups for exacerbations and quality of life.

Conclusions:

  • The Bronchiectasis Severity Index (BSI) is a validated clinical tool.
  • BSI effectively identifies patients at risk for mortality, hospitalization, and exacerbations.
  • The index is applicable across different healthcare systems.